KRAS Kickers featured at AACR
American Association for Cancer Research (AACR) is the first and largest cancer research organization dedicated to accelerating the...
KRAS Kickers featured at AACR
Adagrasib for Patients With Advanced KRAS G12C–Mutated NSCLC
Second Drug Targeting KRAS G12C Shows Benefit in Mutated Non-Small-Cell Lung Cancer
Lilly Announces Details of Presentations at 2021 American Association for Cancer Research
Lilly rejoins KRAS race with swipe at Amgen and Mirati, plans 2021 clinical trial
The Epic Battle with Cancer's 'Death Star'
How Scientists Shot Down Cancer’s ‘Death Star’
Sotorasib Provides Durable Clinical Benefit for Patients with NSCLC and KRAS Mutations
The Improbable Targeted Therapy: KRAS as an Emerging Target in Non-Small Cell Lung Cancer
Hug from Brenda
Need a hug?
SPARK, studying pathways of resistance in KRAS-driven cancers